红细胞免疫相关表面抗原及其功能*

doi:10.3969/j.issn.1671-2587.2024.06.023

临床输血与检验 ›› 2024, Vol. 26 ›› Issue (6): 855-858.DOI: 10.3969/j.issn.1671-2587.2024.06.023

红细胞免疫相关表面抗原及其功能^*

齐畅^1,2, 孟祥红¹

¹解放军总医院第八医学中心输血医学科,北京 100091;
²佳木斯大学基础医学院,黑龙江佳木斯 154007

收稿日期:2024-05-09 出版日期:2024-12-20 发布日期:2024-12-20
通讯作者: 孟祥红,主要从事临床输血与免疫研究,（E-mail）xh5562@sina.com。
作者简介:齐畅,主要从事病原生物学研究,（E-mail）1817592916@qq.com。
基金资助:
*本课题受首都临床特色应用研究与成果推广项目（No.Z161100000516180）资助

Immune-related Surface Antigens and Functional Roles of Red Blood Cells

QI Chang^1,2, MENG Xianghong¹

¹Department of Blood Transfusion Medicine, 8th Medical Center of PLA General Hospital, Beijing 100091,
²Medical College of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang 154007

Received:2024-05-09 Online:2024-12-20 Published:2024-12-20

摘要/Abstract

摘要： 近年来,对红细胞免疫物质的研究结果表明,红细胞不仅是运氧的主要载体,同时也作为固有免疫细胞发挥多种免疫和调节功能。红细胞可通过增强免疫黏附、促进吞噬作用、调节补体活性、清除循环免疫复合物等机制执行免疫调控功能,其表面的免疫物质如TOLL受体9、补体受体1、CD58等可作为桥梁参与维持机体免疫平衡。探索具有免疫特性的红细胞及其细胞因子在机体发育和疾病发生发展中的作用具有重要临床意义。

关键词: 红细胞, 免疫, 细胞因子

Abstract: In recent years, research on immune substances in red blood cells has shown that red blood cells are not only the main carrier of oxygen transportation, but also play a variety of immune and regulatory functions as innate immune cells. These cells are capable of recognizing and adhering to antigens, fostering phagocytosis, engaing with complement system, and eliminating circulating immune complexes. Immune substances on its surface, such as Toll-like receptor 9(TLR9), complement receptor 1 and CD58, can act as bridges to maintain the immune balance of the body. Exploring the role of red blood cells with immune characteristics and their cytokines in the development and progression of diseases has important clinical significance.

Key words: Red blood cells, Immunity, Cytokines

中图分类号:

R392

齐畅, 孟祥红. 红细胞免疫相关表面抗原及其功能^*[J]. 临床输血与检验, 2024, 26(6): 855-858.

QI Chang, MENG Xianghong. Immune-related Surface Antigens and Functional Roles of Red Blood Cells[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 855-858.

参考文献

[1] SIEGEL I,LIU T L,GLEICHER N.The red-cell immune system[J]. Lancet,1981,2(8246):556-559.
[2] ANDERSON H L,BRODSKY I E,MANGALMURTI N S.The evolving erythrocyte: red blood cells as modulators of innate immunity[J]. J Immunol,2018,201(5):1343-1351.
[3] BASTA F,FASOLA F,TRIANTAFYLLIAS K,et al.Systemic lupus erythematosus (SLE) therapy:the old and the new[J]. Rheumatol Ther,2020,7(3):433-446.
[4] XU C L,HE J,WANG H T,et al.Single-cell transcriptomic analysis identifies an immune-prone population in erythroid precursors during human ontogenesis[J].Nat Immunol,2022,23(7):1109-1120.
[5] ZHAO L T,HE R,LONG H X,et al.Late-stage tumors induce Anemia and immunosuppressive extramedullary erythroid progenitor cells[J]. Nat Med,2018,24(10):1536-1544.
[6] HOTZ M J,QING D,SHASHATY M G S,et al. Red blood cells homeostatically bind mitochondrial DNA through TLR9 to maintain quiescence and to prevent lung injury[J].Am J Respir Crit Care Med,2018,197(4):470-480.
[7] METTHEW LAM L K M,MURPHY S,KOKKINAKI D,et al. DNA binding to TLR9 expressed by red blood cells promotes innate immune activation and Anemia[J]. Sci Transl Med,2021,13(616):eabj1008.
[8] BINDER C,CVETKOVSKI F,SELLBERG F,et al.CD2 immunobiology[J]. Front Immunol,2020,11:1090.
[9] ZHANG Y L,LIU Q F,YANG S,et al.CD58 immunobiology at a glance[J]. Front Immunol, 2021,12:705260.
[10] GHEIBIHAYAT S M,CABEZAS R,NIKIFOROV N G,et al.CD47 in the brain and neurodegeneration:an update on the role in neuroinflammatory pathways[J]. Molecules,2021,26(13):3943.
[11] KAZAMA R,MIYOSHI H,TAKEUCHI M,et al.Combination of CD47 and signal-regulatory protein-α constituting the “don't eat me signal” is a prognostic factor in diffuse large B-cell lymphoma[J]. Cancer Sci,2020,111(7):2608-2619.
[12] WANG F,LIU Y H,ZHANG T,et al.Aging-associated changes in CD47 arrangement and interaction with thrombospondin-1 on red blood cells visualized by super-resolution imaging[J]. Aging Cell,2020,19(10):e13224.
[13] OLIVEIRA L C,KRETZSCHMAR G C,DOS SANTOS A C M,et al. Complement receptor 1 (CR1,CD35) polymorphisms and soluble CR1:a proposed anti-inflammatory role to quench the fire of “fogo selvagem” Pemphigus foliaceus[J]. Front Immunol, 2019,10:2585.
[14] OLIVEIRA L C,KRETZSCHMAR G C,DOS SANTOS A C M,et al. Complement receptor 1 (CR1,CD35) polymorphisms and soluble CR1:a proposed anti-inflammatory role to quench the fire of “fogo selvagem” Pemphigus foliaceus[J]. Front Immunol,2019,10:2585.
[15] KISSERLI A,SCHNEIDER N,AUDONNET S,et al.Acquired decrease of the C3b/C4b receptor (CR1,CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients[J]. Immunobiology, 2021,226(3):152093.
[16] BOERO E,GORHAM R D Jr,FRANCIS E A,et al. Purified complement C3b triggers phagocytosis and activation of human neutrophils via complement receptor 1[J]. Sci Rep,2023,13(1):274.
[17] ASOK KUMAR N,MURALEEDHARAN SUMA S,KUNNAKKADAN U,et al.Functional dissection of the dominant role of CD55 in protecting vesicular stomatitis virus against complement-mediated neutralization[J].Viruses,2021,13(3):373.
[18] COLDEN M A,KUMAR S,MUNKHBILEG B,et al.Insights into the emergence of paroxysmal nocturnal hemoglobinuria[J]. Front Immunol,2022,12:830172.
[19] SHAKYA B,PATEL S D,TANI Y,et al.Erythrocyte CD55 mediates the internalization of Plasmodium falciparum parasites[J]. eLife,2021,10:e61516.
[20] BHARTI R,DEY G,LIN F,et al.CD55 in cancer: Complementing functions in a non-canonical manner[J]. Cancer Lett,2022,551:215935.
[21] YIN X N,SHEN C Y,YIN Y,et al.Overexpression of CD55 correlates with tumor progression and poor prognosis in gastric stromal tumors[J]. Onco Targets Ther,2019,12:4703-4712.
[22] WEINSTOCK C.Association of blood group antigen CD59 with disease[J]. Transfus Med Hemother,2022,49(1):13-24.
[23] ZHANG R H,LIU Q F,LIAO Q,et al.CD59:a promising target for tumor immunotherapy[J]. Future Oncol,2018,14(8):781-791.
[24] VAN ALSTEN S C,AVERSA J G,SANTO L,et al. Association between ABO and Duffy blood types and circulating chemokines and cytokines[J]. Genes Immun,2021,22(3):161-171.
[25] REN Y J,YAN C K,YANG H.Erythrocytes:Member of the immune system that should not be ignored[J]. Crit Rev Oncol Hematol,2023,187:104039.
[26] HILLARY R F,TREJO-BANOS D,KOUSATHANAS A,et al.Multi-method genome-and epigenome-wide studies of inflammatory protein levels in healthy older adults[J]. Genome Med,2020,12(1):60.
[27] KLEI T R L,AGLIALORO F,MUL F P J,et al. Differential interaction between DARC and SDF-1 on erythrocytes and their precursors[J]. Sci Rep,2019,9(1):16245.
[28] ELAHI S.Neglected cells:immunomodulatory roles of CD71+ erythroid cells[J]. Trends Immunol, 2019,40(3):181-185.
[29] ELAHI S,VEGA-LÓPEZ M A,HERMAN-MIGUEL V,et al. CD71+ erythroid cells in human neonates exhibit immunosuppressive properties and compromise immune response against systemic infection in neonatal mice[J]. Front Immunol,2020,11:597433.
[30] GRZYWA T M,NOWIS D,GOLAB J.The role of CD71+ erythroid cells in the regulation of the immune response[J]. Pharmacol Ther,2021,228:107927.
[31] MILLER D,ROMERO R,UNKEL R,et al.CD71+ erythroid cells from neonates born to women with preterm labor regulate cytokine and cellular responses[J]. J Leukoc Biol,2018,103(4):761-775.
[32] DELYEA C,BOZORGMEHR N,KOLEVA P,et al.CD71+ erythroid suppressor cells promote fetomaternal tolerance through arginase-2 and PDL-1[J]. J Immunol, 2018,200(12):4044-4058.
[33] 李悦,石莉红. 红细胞免疫调控功能的研究进展[J]. 中国细胞生物学学报,2022,44(1):59-67.

红细胞免疫相关表面抗原及其功能^*

Immune-related Surface Antigens and Functional Roles of Red Blood Cells

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	庄远, 于洋. 输血（医学）科基于离心分离技术建立单采/血液净化治疗体系的探索[J]. 临床输血与检验, 2024, 26(6): 721-725.
[2]	朱心怡, 张成鑫, 王秋实, 李佳佳, 齐永, 向东, 赵俸涌. 常见红细胞添加剂成分对双花扁豆凝集素与A₁红细胞反应的影响^*[J]. 临床输血与检验, 2024, 26(5): 587-591.
[3]	蒋雪玉, 杨懿铭, 孙娟, 谢如锋, 高跞, 杨洁. 黄芩苷预治疗对小鼠红细胞输注模型中IgG和IgM抑制作用的研究^*[J]. 临床输血与检验, 2024, 26(5): 604-608.
[4]	苏晓敏, 张国权, 王锦, 徐华. 基于蛋白组学和代谢组学在血液存储中相关性分析[J]. 临床输血与检验, 2024, 26(5): 609-616.
[5]	王静, 罗景艳, 张洁, 张涵奕, 张洪为, 黄远帅. 红细胞衍生的细胞外囊泡对红细胞储存损伤的初步研究[J]. 临床输血与检验, 2024, 26(5): 624-629.
[6]	范成艳, 温玉洁, 廉雪, 张丹, 王洁, 敬媛媛, 王丽君, 李伟, 贾延军, 李冬妹. 免疫性血小板输注无效患者血清中血小板相关抗体的变化及其临床意义^*[J]. 临床输血与检验, 2024, 26(5): 661-666.
[7]	胡俊华, 韩剑峰, 王鹏, 夏荣, 刘凤华, 杨江存, 桂嵘, 刘娟, 秦莉, 杜春红, 李喜莹, 吕先萍, 殷鹏, 宫济武. HBV、HCV、HIV血筛多中心研究免疫学灰区的核酸检测分析与临床特征研究[J]. 临床输血与检验, 2024, 26(5): 675-679.
[8]	杨颖, 李子涵, 丁旭苹, 张嘉敏, 李勤, 郭忠慧, 赵俸涌, 杨启修, 王晨, 路丽明, 朱自严. 肿瘤抗原肽的HLA限制性确认和诱导反应性T细胞杀瘤能力评估^*[J]. 临床输血与检验, 2024, 26(4): 433-439.
[9]	李勤, 赵俸涌, 张嘉敏, 杨颖, 郭忠慧, 王晨, 杨启修, 朱自严. NLRP3炎性小体对THP-1细胞吞噬老化红细胞后亚类分化的调控^*[J]. 临床输血与检验, 2024, 26(4): 457-462.
[10]	王雨婧, 马海梅. 纳米酶应用于抵抗红细胞氧化损伤可行性的初步研究[J]. 临床输血与检验, 2024, 26(4): 484-490.
[11]	红细胞血型抗原拓展匹配适用范围中国专家共识编写组. 红细胞血型抗原拓展匹配适用范围中国专家共识[J]. 临床输血与检验, 2024, 26(3): 289-298.
[12]	孟炜程, 陈要臻, 王雅芬, 安宁, 刘志新, 吴晓双, 王斐, 胡兴斌. 致敏红细胞BPGM酶活性降低对红细胞携氧/释氧能力的影响研究^*[J]. 临床输血与检验, 2024, 26(3): 308-314.
[13]	陈婷婷, 黄蓉, 凌玉, 胡文静. RhD阴性孕产妇与HDFN发生的相关性及影响因素分析^*[J]. 临床输血与检验, 2024, 26(3): 338-345.
[14]	范成艳, 温玉洁, 张丹, 廉雪, 刘娜, 孙铁成, 王东梅, 贾延军, 李冬妹. 免疫性血小板输注无效患者HLA/HPA抗体特性分析及其对血小板输注效果的影响^*[J]. 临床输血与检验, 2024, 26(3): 353-358.
[15]	甘丽, 易平, 赵勤俭, 张馨元. 基于红细胞的疫苗载体研究进展^*[J]. 临床输血与检验, 2024, 26(3): 404-411.